"10.1371_journal.pone.0030586","plos one","2012-01-26T00:00:00Z","Andrea L Hinds; Erik Z Woody; Michael Van Ameringen; Louis A Schmidt; Henry Szechtman","Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada; Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada; Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, Ontario, Canada","Conceived and designed the experiments: ALH EZW MVA LAS HS. Performed the experiments: ALH MVA. Analyzed the data: ALH EZW MVA LAS HS. Contributed reagents/materials/analysis tools: LAS. Wrote the paper: ALH EZW MVA LAS HS.","Ms. Hinds, Dr. Woody, Dr. Schmidt, and Dr. Szechtman report no competing interests. In the last 24 months, Dr. Van Ameringen has received research grant support from the Canadian Foundation for Innovation (CFI), Janssen-Ortho Inc., NIH (National Institutes of Health), Pfizer Inc., Shire, and Wyeth-Ayerst. He is a member of the Speakers Bureau for Biovail, GlaxoSmithKline, Janssen-Ortho Inc., Lundbeck, and Pfizer Inc. He has participated in advisory boards for Astra Zeneca, Biovail, Eli Lilly, Janssen-Ortho Inc., Labo Pharm, Lundbeck, Pfizer Inc., Servier, Shire and Valiant. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","01","Andrea L Hinds","ALH",5,FALSE,5,2,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
